Search results
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks· 3 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. Over the past month, shares of this biotechnology company have returned +11.6%, compared to the Zacks S&P 500 composite's ...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 1 hour agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 days agoModerna Inc (MRNA, Financial) has recently shown a notable daily gain of 5.55%, with a three-month gain of 34.21%. Despite these impressive numbers, a deeper look into the ...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 6 days agoModerna (NASDAQ:MRNA) shares are down just over 1% in early Friday trading after the company said...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 6 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via AOL· 41 minutes agoThe U.S. contracted with AstraZeneca early in the pandemic for the delivery of 300 million doses of...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 3 days agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 6 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 6 days agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 6 days agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...